Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma

Eyles, Jo, Puaux, Anne-Laure, Wang, Xiaojie, Toh, Benjamin, Prakash, Celine, Hong, Michelle, Tan, Tze Guan, Zheng, Lin +7 more·2010·Journal of Clinical Investigation

Cited by (505)

Items 101–200 of 505

  1. Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis
    Nicolas Malaquin, Chantal Vercamer, Fatima Bouali, Sébastien Martien, Emeric Deruy, Nicolas Wernert, Maggy Chwastyniak, Florence Pinet, Corinne Abbadie, Albin Pourtier · 2013 · PLoS ONE
  2. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities
    Omri Hen, Dalit Barkan · 2019 · Seminars in Cancer Biology
  3. CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer
    Paulino Tallón de Lara, Héctor Castañón, Marijne Vermeer, Nicolás Gonzalo Núñez, Karīna Siliņa, Bettina Sobottka, Joaquín Urdinez, Virginia Cecconi, Hideo Yagita∥, Farkhondeh Movahedian Attar et al. · 2021 · Nature Communications
  4. Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’
    Alicia‐Marie Conway, Claire L. Mitchell, Elaine Kilgour, Gerard Brady, Caroline Dive, Natalie Cook · 2018 · British Journal of Cancer
  5. Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
    Antonella Sistigu, Martina Musella, Claudia Galassi, Ilio Vitale, Ruggero D. Maria · 2020 · Frontiers in Immunology
  6. Regulation of COX2 Expression in Mouse Mammary Tumor Cells Controls Bone Metastasis and PGE2-Induction of Regulatory T Cell Migration
    John Karavitis, Laura M. Hix, Yihui H. Shi, Rachael F. Schultz, Khashayarsha Khazaie, Ming Zhang · 2012 · PLoS ONE
  7. Biology of advanced uveal melanoma and next steps for clinical therapeutics
    Jason J. Luke, Pierre L. Triozzi, Kyle Christopher McKenna, Erwin G. Van Meir, Jeffrey E. Gershenwald, Boris C. Bastian, Jorge Silvio Gutkind, Anne M. Bowcock, HOWARD Z. STREICHER, Poulam M. Patel et al. · 2014 · Pigment Cell & Melanoma Research
  8. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy
    Christiana Michael Neophytou, Theodora-Christina Kyriakou, Panagiotis Papageorgis · 2019 · International Journal of Molecular Sciences
  9. Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
    Francisco Triana-Martínez, Marı́a Isabel Loza, Eduardo Domínguez · 2020 · Cells
  10. ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung
    Ana Rita Nobre, Erica Dalla, Jihong Yang, Xin Huang, Lena Wullkopf, Emma Risson, Pedram Razghandi, Melisa Lopez Anton, Wei Zheng, José Antonio Seoane et al. · 2022 · Nature Cancer
  11. Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor Progression
    Peter J. Chockley, Venkateshwar G. Keshamouni · 2016 · The Journal of Immunology
  12. Recent advances in understanding the complexities of metastasis
    Jessica L. Chitty, Elysse C. Filipe, Morghan C. Lucas, David Herrmann, Thomas R. Cox, Paul Timpson · 2018 · F1000Research
  13. Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
    Melanie Werner‐Klein, Sebastian Scheitler, Martin Hoffmann, Isabelle Hodak, Klaus Dietz, Petra Lehnert, Veronika Naimer, Bernhard Michael Polzer, Steffi Treitschke, Christian Werno et al. · 2018 · Nature Communications
  14. Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
    Michel J.P. DuPage, Tyler Jacks · 2013 · Current Opinion in Immunology
  15. Concepts of metastasis in flux: The stromal progression model
    Jonathan Paul Sleeman, Gerhard Christofori, Riccardo Fodde, John G. Collard, Geert Berx, Charles Decraene, Curzio Rüegg · 2012 · Seminars in Cancer Biology
  16. Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival
    Gary G. Meadows · 2015 · Alcohol research
  17. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies
    Kimberly Mayumi Komatsubara, Richard D. Carvajal · 2017 · Current Oncology Reports
  18. Progressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytes
    Chapon, Maxime, Randriamampita, Clotilde, Maubec, Eve, Badoual, Cécile, Fouquet, Stéphane, Wang, Shu-Fang, Marinho, Eduardo, Farhi, David, Garcette, Marylène, Jacobelli, Simon et al. · 2011 · Journal of Investigative Dermatology
  19. Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
    Vincenzo Ingangi, Michele Minopoli, Concetta Ragone, Maria Letizia Motti, Maria Vincenza Carriero · 2019 · Frontiers in Oncology
  20. Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer
    Irene Romero, Federico Garrido, Angel Miguel Garcia-Lora · 2014 · Cancer Research
  21. Pembrolizumab as first-line treatment for metastatic uveal melanoma
    Ernesto Rossi, Monica Maria Pagliara, Daniela Orteschi, Tommaso Dosa, Maria Grazia Sammarco, Carmela Grazia Caputo, Gianluigi Petrone, Guido Rindi, Marcella Zollino, Maria Antonietta Blasi et al. · 2019 · Cancer Immunology Immunotherapy
  22. Emerging Topics on Disseminated Cancer Cell Dormancy and the Paradigm of Metastasis
    Julio A. Aguirre‐Ghiso, María Soledad Sosa · 2018 · Annual Review of Cancer Biology
  23. Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer
    Maria A. Papadaki, Anastasios V. Koutsopoulos, Panormitis G Tsoulfas, Eleni D. Lagoudaki, Despoina Aggouraki, Alexia A Monastirioti, Chara Koutoulaki, Christina A Apostolopoulou, Aikaterini C. Merodoulaki, Chara Papadaki et al. · 2020 · Cancers
  24. Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma
    Ludovic Jean Wrobel, Lloyd Bod, Renée Lengagne, Masashi Kato, Armelle Prévost‐Blondel, Frédérique‐Anne Le Gal · 2016 · Oncotarget
  25. Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
    Emmanuel Donnadieu, Loı̈c Dupré, Lia Gonçalves Pinho, Vinı́cius Cotta-de-Almeida · 2020 · Journal of Leukocyte Biology
  26. Cell-intrinsic and microenvironmental determinants of metastatic colonization
    Arthur W. Lambert, Yun Zhang, Robert A. Weinberg · 2024 · Nature Cell Biology
  27. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts
    Kathryn E. Hamilton, Felicite Kamdem Noubissi, Prateek S. Katti, Christopher M. Hahn, Sonya R. Davey, Emma T. Lundsmith, Andres J. Klein–Szanto, Andrew D. Rhim, Vladimir S. Spiegelman, Anil K. Rustgi · 2013 · Carcinogenesis
  28. Innate and acquired immune surveillance in the postdissemination phase of metastasis
    Hugo González Velozo, Isabella Robles, Zena Werb · 2017 · FEBS Journal
  29. Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
    Hao Wang, Junjie Pan, Livnat Barsky, Jule Caroline Jacob, Yan Zheng, Chao Gao, Shun Wang, Wenwei Zhu, Haoting Sun, Lu Lu et al. · 2021 · Molecular Biomedicine
  30. Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer
    Frédérique Végran, Lionel Apétoh, François Ghiringhelli · 2015 · Cancer Research
  31. Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies
    Jing Liu, Stephen J. Blake, Mark John Smyth, Michele W.L. Teng · 2014 · Clinical & Translational Immunology
  32. The critical role of bisphosphonates to target bone cancer metastasis: an overview
    Tejinder Singh, Veerpal Kaur, Manish Kumar, Prabhjot Kaur, R. S. R. Murthy, Ravindra Kumar Rawal · 2014 · Journal of drug targeting
  33. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4 + T cells
    Arnaud Pommier, Alexandra Audemard‐Verger, Aurélie Durand, Renée Lengagne, Arnaud Delpoux, Bruno Martin, Laëtitia Douguet, Armelle Le Campion, Masashi Kato, Marie‐Françoise Avril et al. · 2013 · Proceedings of the National Academy of Sciences
  34. Inhibition of Ron Kinase Blocks Conversion of Micrometastases to Overt Metastases by Boosting Antitumor Immunity
    Henok Eyob, H. Atakan Ekiz, Yoko S. DeRose, Susan E. Waltz, Matthew A. Williams, Alana L. Welm · 2013 · Cancer Discovery
  35. Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
    Fang Zhao, Antje Sucker, Susanne Horn, Christina Heeke, Nicola Bielefeld, Barbara Schrörs, Anne Bicker, Monika Lindemann, Alexander Roesch, Gustav Gaudernack et al. · 2016 · Cancer Research
  36. T Lymphocytes Restrain Spontaneous Metastases in Permanent Dormancy
    Irene Romero, Cristina Garrido, Ignacio Algarra, Antonia Collado, Federico Garrido, Angel Miguel Garcia-Lora · 2014 · Cancer Research
  37. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype
    Qing Cheng, Jeffrey T. Chang, William Rayford Gwin, Jun Zhu, Stefan Ambs, Joseph Geradts, Herbert Kim Lyerly · 2014 · Breast Cancer Research
  38. Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
    Maxime Thoreau, Hweixian Leong Penny, Kar Wai Tan, Fabienne Régnier, Julia Miriam Weiss, Bernett Teck Kwong Lee, Ludger Johannes, Estelle Dransart, Agnès Le Bon, Jean‐Pierre Abastado et al. · 2015 · Oncotarget
  39. Implantable pre-metastatic niches for the study of the microenvironmental regulation of disseminated human tumour cells
    Ryan Carpenter, Jun‐Goo Kwak, Shelly R. Peyton, Jungwoo Lee · 2018 · Nature Biomedical Engineering
  40. EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper cells
    Suyasha Roy, Zaigham Abbas Rizvi, Alexander J. Clarke, Felicity Macdonald, Abhaydeep Pandey, Dietmar M. W. Zaiss, Anna Katharina Simon, Amit Awasthi · 2021 · Nature Communications
  41. The epigenetic/noncoding origin of tumor dormancy
    Francesco Crea, Nur Ridzwan Nur Saidy, Colin C. Collins, Yuzhuo Z. Wang · 2015 · Trends in Molecular Medicine
  42. Vascular channels formed by subpopulations of PECAM1+ melanoma cells
    James M. Dunleavey, Lin Xiao, Joshua Thompson, Mimi Kim, Janiel M. Shields, Sarah E. Shelton, David Irvin, Victoria E. Brings, David W. Ollila, Rolf A. Brekken et al. · 2014 · Nature Communications
  43. Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
    Massimiliano Mazzone, Gabriele Bergers · 2019 · Annual Review of Physiology
  44. Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages
    Alessio Menga, Marina Serra, Simona Todisco, Carla Riera‐Domingo, Ummi Ammarah, Manuel Ehling, Erika Mariana Palmieri, Maria Antonietta Di Noia, Rosanna Gissi, Maria Favia et al. · 2020 · EMBO Molecular Medicine
  45. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis
    MARION DAVID, Johnny Ribeiro, Françoise Descôtes, Claire‐Marie Serre, MARYSE BARBIER, Maximilien Murone, Philippe Clézardin, Olivier Peyruchaud · 2011 · International Journal of Oncology
  46. LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells
    Dhiraj Kumar, Sreeharsha Gurrapu, Yan Wang, Seong‐Yeon Bae, Poonam R. Pandey, Hong Chen, Jayanta Mondal, Hyun Ho Han, Chang‐Jiun Wu, Spyros Karaiskos et al. · 2024 · Nature Cancer
  47. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
    Amit Singh Yadav, Poonam R. Pandey, Ramesh Butti, N. N. V. Radharani, Shamayita Roy, Shaileshkumar R. Bhalara, Mahadeo Gorain, Gopal C. Kundu, Dhiraj Kumar · 2018 · Frontiers in Oncology
  48. The tumor macroenvironment and systemic regulation of breast cancer progression
    Zafira Castaño, Kristin Tracy, Sandra S. McAllister · 2011 · The International Journal of Developmental Biology
  49. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors
    Isabel Heidrich, Benjamin Deitert, Stefan Werner, Klaus Pantel · 2023 · Cancer and Metastasis Reviews
  50. Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State
    Constantin N. Baxevanis, Sonia A. Perez · 2015 · Vaccines
  51. TGF‐β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up‐regulation of IL‐17RB
    Shih‐Chia Huang, Pei‐Chi Wei, Wendy W. Hwang‐Verslues, Wen‐Hung Kuo, Yung‐Ming Jeng, Chun‐Mei Hu, Jin‐Yuh Shew, Chiun‐Sheng Huang, King‐Jen Chang, Eva Y‐HP Lee et al. · 2017 · EMBO Molecular Medicine
  52. Down-Regulation of CDH1 Is Associated with Expression of SNAI1 in Colorectal Adenomas
    F Kröpil, Georg Fluegen, Тотиков Заурбек Валерьевич, Stephan Ernst Baldus, Christian Vay, Matthias C. Schauer, Stefan Andreas Topp, Jan Schulte Am Esch, Wolfram Trudo Knoefel, Nikolas Hendrik Stoecklein · 2012 · PLoS ONE
  53. Tumor Dormancy: Implications for Invasion and Metastasis
    Georgia Gomatou, Nikolaos Konstantinos Syrigos, Ioannis Athanasios Vathiotis, Elias Alexandros Kotteas · 2021 · International Journal of Molecular Sciences
  54. Rethinking the biology of metastatic melanoma: a holistic approach
    Hendrik HLD Vandyck, Lisa Maria Hillen, Francesca Maria Bosisio, Joost van den Oord, Axel zur Hausen, Veronique J.L. Winnepenninckx · 2021 · Cancer and Metastasis Reviews
  55. Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse
    Saeed H. Manjili, Madison Isbell, Negar Ghochaghi, Tyler Perkinson, Masoud H. Manjili · 2021 · Seminars in Cancer Biology
  56. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion
    Odile Berthier‐Vergnes, Manale El Kharbili, Arnaud de la Fouchardière, Thomas Pointecouteau, Patrick Verrando, Anne Wierinckx, Joël Lachuer, François Le Naour, Jérôme Lamartine · 2010 · British Journal of Cancer
  57. Locally sourced: site-specific immune barriers to metastasis
    Ana Luísa Correia · 2023 · Nature reviews. Immunology
  58. Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years
    Simona Osella‐Abate, Simone Ribero, Martina Sanlorenzo, Milena Maria Maule, Lorenzo Richiardi, Franco Merletti, Carlo Francesco Tomasini, Elena Marra, Giuseppe Macripò, Maria Teresa Fierro et al. · 2014 · International Journal of Cancer
  59. The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor
    Jean‐Pierre Abastado · 2012 · Cancer Research
  60. Mechanisms of Metastatic Tumor Dormancy
    Mary Osisami, Evan T. Keller · 2013 · Journal of Clinical Medicine
  61. Tuning cancer fate: the unremitting role of host immunity
    Bianca Calì, Barbara Molon, Antonella Viola · 2017 · Open Biology
  62. Cell Fusion in Human Cancer: The Dark Matter Hypothesis
    Julian Weiler, Thomas Dittmar · 2019 · Cells
  63. Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
    Lambert C. J. Dorssers, Ad Gillis, Hans Stoop, Ronald van Marion, Marleen M. Nieboer, Job van Riet, Harmen J.G. van de Werken, J. Wolter Oosterhuis, Jeroen de Ridder, Leendert H. J. Looijenga · 2019 · British Journal of Cancer
  64. Uveal melanoma: progress in molecular biology and therapeutics
    Yongyun Li, Jiahao Shi, Jie Yang, Shengfang Ge, Jianming Zhang, Renbing Jia, Xianqun Fan · 2020 · Therapeutic Advances in Medical Oncology
  65. Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis
    Ward Celus, Giusy Di Conza, Ana Isabel Oliveira, Manuel Ehling, Bruno Marques Costa, Mathias Wenes, Massimiliano Mazzone · 2017 · Cell Reports
  66. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
    Carl A. Shirley, Gagan Chhabra, Deeba Amiri, Hao Chang, Nihal Ahmad · 2024 · Frontiers in Immunology
  67. Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance
    Yanhong Xiao, Mahan Hassani, Melina Barahouei Moghaddam, Ahmad Fazilat, Masoud Ojarudi, Mohammad Valilo · 2025 · Medical Oncology
  68. Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer
    Kabir A. Khan, Florence T.H. Wu, William Cruz‐Muñoz, Robert S. Kerbel · 2021 · EMBO Molecular Medicine
  69. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis
    Swadesh Kumar Das, Santanu Maji, Stephen L. Wechman, Praveen Bhoopathi, Anjan K. Pradhan, Sarmistha Talukdar, Devanand Sarkar, Joseph W. Landry, Chunqing Guo, Xiang‐Yang Wang et al. · 2020 · Pharmacological Research
  70. Metastatic Colonization: Escaping Immune Surveillance
    Julien Schaller, Judith Agudo · 2020 · Cancers
  71. Physical Activity and Breast Cancer Prevention: Possible Role of Immune Mediators
    Yitong Xu, Connie Jo Rogers · 2020 · Frontiers in Nutrition
  72. Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer
    Haofan Wang, Shasha Wang, Mei-chang Huang, Xin‐hua Liang, Ya-Jie Tang, Ya‐ling Tang · 2019 · Frontiers in Oncology
  73. The paradox of radiation and T cells in tumors
    Michael J. Gough, Marka R. Crittenden · 2022 · Neoplasia
  74. The immune-related role of beta-2-microglobulin in melanoma
    Chuqiao Wang, Zeqi Wang, Tengteng Yao, Jibo Zhou, Zhaoyang Wang · 2022 · Frontiers in Oncology
  75. Bidirectional Crosstalk between Lymphatic Endothelial Cell and T Cell and Its Implications in Tumor Immunity
    Kim Pin Yeo, Véronique Angeli · 2017 · Frontiers in Immunology
  76. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications
    Federico Rossari, Cristina Zucchinetti, Gabriele Buda, Enrico Orciuolo · 2019 · Cellular Oncology
  77. Single‐cell RNA‐seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression
    Bo Pang, Jinyuan Xu, Jing Rong Hu, Fenghua Guo, Linyun Wan, Mingjiang Cheng, Lin Pang · 2019 · Molecular Oncology
  78. Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma
    Muly Tham, Karen Khoo, Kim Pin Yeo, Masashi Kato, Armelle Prévost‐Blondel, Véronique Angeli, Jean‐Pierre Abastado · 2015 · Oncotarget
  79. Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases
    Bettina Sobottka, Bernhard C. Pestalozzi, Daniel A. Fink, Holger Moch, Zsuzsanna Varga · 2016 · OncoImmunology
  80. Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
    Jackson R. Richards, Jae Hyuk Yoo, Donghan Shin, Shannon J. Odelberg · 2019 · Pigment Cell & Melanoma Research
  81. Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels
    Xiaobo Liu, Yuanyuan Wang, Alexander Thomas Bauer, Michael Kirschfink, Peipei Ding, Christoffer Gebhardt, Lubor Borsig, Thomas Tüting, Thomas Renné, Karsten Häffner et al. · 2022 · Proceedings of the National Academy of Sciences
  82. Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
    Bala Sai Sundarasetty, Lucas Chan, D Darling, G Giunti, Farzin Farzaneh, Florian Schenck, Sonja Naundorf, Klaus Kuehlcke, Eliana Ruggiero, Manfred Schmidt et al. · 2015 · Gene Therapy
  83. Metastatic mechanisms in follicular cell-derived thyroid cancer
    John E. Phay, Matthew David Ringel · 2013 · Endocrine Related Cancer
  84. Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow–Resident Melanoma CTCs
    Monika Vishnoi, Debasish Boral, Haowen Liu, Marc L. Sprouse, Wei Hsian Yin, Debalina Goswami-Sewell, Michael T. Tetzlaff, Michael A. Davies, Isabella C. Glitza Oliva, Dario Marchetti · 2018 · Cancer Research
  85. CD8 + T cell immunity blocks the metastasis of carcinogen-exposed breast cancer
    Kaiwen Li, Tiancheng Li, Zhaoyi Feng, Mei Huang, Lei Wei, Zhiyu Yan, Mark D. Long, Qiang Hu, Jianmin Wang, Song Liu et al. · 2021 · Science Advances
  86. Roles of exosomes in metastatic colorectal cancer
    Marie Lafitte, Céline Lecointre, Serge Roche · 2019 · American Journal of Physiology-Cell Physiology
  87. Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells
    Tarun Tyagi, Kanika Jain, Timur Olegovich Yarovinsky, Michael Chiorazzi, Jing Du, Cecilia Castro, Julian Leether Griffin, Asawari Korde, Kathleen A. Martin, Shervin S. Takyar et al. · 2022 · The Journal of Experimental Medicine
  88. Fibronectin 1 derived from tumor-associated macrophages and fibroblasts promotes metastasis through the JUN pathway in hepatocellular carcinoma
    Liwei Zhang, Cong Zhang, Zhengwei Xing, Chunyang Lou, Jianbang Fang, Zhiwei Peter Wang, Mingxing Li, Hao He, Hualong Bai · 2022 · International Immunopharmacology
  89. Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation
    Muly Tham, Kar Wai Tan, Jo Keeble, Xiaojie Wang, Sandra Hubert, Luke Barron, Nguan Soon Tan, Masashi Kato, Armelle Prévost‐Blondel, Véronique Angeli et al. · 2014 · Oncotarget
  90. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways
    Fei-Fei Gan, Hui Yvonne Ling, Xiaohui Ang, Shridhivya A. Reddy, Stephanie S-H. Lee, Hong Yang, Sock-Hoon Tan, John D. Hayes, Wai‐Keung Chui, Eng‐Hui Chew · 2013 · Toxicology and Applied Pharmacology
  91. Determinants of Organotropic Metastasis
    Heath A. Smith, Yibin Kang · 2016 · Annual Review of Cancer Biology
  92. Tumor cell dormancy as an adaptive cell stress response mechanism
    Laura Vera Ramírez, Kent W. Hunter · 2017 · F1000Research
  93. Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis
    Stacy K. Thomas, Jesse Lee, Gregory Lawrence Beatty · 2020 · EBioMedicine
  94. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention
    Vasilia Tamamouna, Evangelia Pavlou, Christiana Michael Neophytou, Panagiotis Papageorgis, Paul Costeas · 2022 · International Journal of Molecular Sciences
  95. T cell exhaustion in human cancers
    Kuan Kang, Xin Lin, Pan Chen, Huai Liu, Feng Liu, Wei Xiong, Guiyuan Li, Mei Yi, Xiayu Li, Hui Wang et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  96. Tumor extracellular vesicles drive metastasis (it's a long way from home)
    Shima Ghoroghi, Benjamin Mary, Nandini Asokan, Jacky G. Goetz, Vincent Hyenne · 2021 · FASEB BioAdvances
  97. Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
    Qiang Yu, Jiajun Ding, Shisen Li, Yunlong Li · 2024 · Cancer Letters
  98. Evolutionary perspective of cancer: myth, metaphors, and reality
    Audrey Arnal, Beáta Újvári, Bernard J. Crespi, Robert A. Gatenby, Tazzio Tissot, Marion Vittecoq, Paul W. Ewald, Andreu Casali, Hugo Ducasse, Camille M. Jacqueline et al. · 2015 · Evolutionary Applications
  99. CD271 determines migratory properties of melanoma cells
    Josefine Radke, Florian Roßner, Torben Redmer · 2017 · Scientific Reports
  100. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities
    Ganesan Ramamoorthi, Krithika Nandakumar Kodumudi, Corey Gallen, Nadia Nocera Zachariah, Amrita B Basu, Gabriella K. Albert, Amber Beyer, Colin Snyder, Doris A. Wiener, Ricardo Lima Barros Costa et al. · 2021 · Seminars in Cancer Biology